Hims & Hers Health falls as much as 17%, biggest drop since February

A single-day drawdown of this size in a consumer telehealth name is a reminder that richly valued growth equities remain the most rate- and sentiment-sensitive corner of the market, even when the underlying business is far from crypto. The move matters less for the company itself than as a read on risk appetite for high-multiple, direct-to-consumer platforms that sit adjacent to the broader digital-health and wellness economy. The open question is whether this is an isolated repricing or the start of a wider de-rating across similar names; follow-through in comparable listings would be the tell.